title: Erbium:YAG laser sclerectomy with a sapphire optical fiber.
abstract: OBJECTIVE
  Laser sclerectomy may offer advantages to conventional glaucoma filtering surgery by minimizing conjunctival manipulation and subsequent subconjunctival scarring and by providing easier access to difficult locations. It has been theorized that minimizing collateral thermal damage may enhance the success rate and reduce complications associated with laser sclerectomy. The thermal damage induced by the pulsed erbium:yttrium aluminum garnet (Er:YAG) laser is notably less than that of other laser modalities, including neodymium:YAG (1.06 microns), Er:YSGG (2.79 microns), holmium: YAG (2.10 microns), and holmium: YSGG (2.10 microns). A major obstacle to the clinical use of the Er:YAG laser has been the lack of an efficient and reliable delivery system. The single-crystal sapphire optical fiber has an acceptable attenuation rate and favorable characteristics for delivery of the Er:YAG wave-length in a clinical setting.
  
  
  METHODS
  An Er:YAG laser (2.94 microns) focused into a 300-micron, single-crystal sapphire fiber was used to create ab-externo sclerectomies with varying energy levels and pulse rates in each eye of six anesthetized rabbits and six human cadaver eyes. Specimens then underwent histopathologic analysis and determination of the thermal damage zone.
  
  
  RESULTS
  For the rabbit sclerectomies, there was a significant positive correlation between energy per pulse and the diameter of the thermal damage zone, which averaged 22.0 +/- 12.7 microns for all energy levels. For the human sclerectomies, a positive correlation existed between the total energy delivered (mJ/pulse x total pulses) and the thermal damage zone, with the mean thermal damage zone, being 25.0 +/- 9.0 microns.
  
  
  CONCLUSIONS
  The Er:YAG laser with a sapphire optical fiber delivery system is an effective means of creating ab-externo sclerectomies with minimal thermal damage.
authors.affiliation: New England Eye Center, New England Medical Center, Tufts University School of Medicine, Boston, MA 02111, USA.
authors.forename: M L
authors.initials: ML
authors.lastname: McHam
authors.forename: D L
authors.initials: DL
authors.lastname: Eisenberg
authors.forename: J S
authors.initials: JS
authors.lastname: Schuman
authors.forename: N
authors.initials: N
authors.lastname: Wang
mesh_terms: D000818:Animals; D005901:Glaucoma / Q000601:surgery; D006801:Humans; D053685:Laser Therapy / Q000295:instrumentation*; D010865:Pilot Projects; D011817:Rabbits; D012590:Sclera / Q000473:pathology / Q000601:surgery*; D012599:Sclerostomy / Q000379:methods*; D016896:Treatment Outcome